| Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1) (NCT04554966) | AbbVie | 2021-04-16 |
| Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV) (NCT04799353) | AbbVie | 2021-03-15 |
| Community Based Screening for HIV Self Testing in FSW in 23 Priority Districts in Indonesia (NCT04578145) | Kerti Praja Foundation | 2020-04-17 |
| A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1 (NCT04223804) | AbbVie | 2020-01-30 |
| Alcohol Monitor Validation (NCT03617705) | University of Florida | 2019-04-01 |
| Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults (NCT03783130) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-03-07 |
| Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents (NCT03800394) | University of Florida | 2019-01-28 |
| Mitochondria in HIV and Aging (MITO+) (NCT03489421) | University of Colorado, Denver | 2018-12-15 |
| An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate (NCT03577470) | Janssen-Cilag S.p.A. | 2018-06-13 |
| Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux (NCT03290755) | University Hospital, Bordeaux | 2017-11-08 |
| The Effect of Ixazomib on the Latent HIV Reservoir (NCT02946047) | Mayo Clinic | 2017-03-20 |
| NC Young Women's CoOp (NCT02965014) | RTI International | 2017-01-18 |
| Romidepsin Plus 3BNC117 Phase 2a Study (NCT02850016) | Rockefeller University | 2017-01-06 |
| An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study (NCT02990858) | CytoDyn, Inc. | 2016-11-03 |
| Cape Town Young Women's Health CoOp (NCT02974998) | RTI International | 2016-11-01 |
| New Strategies to Assess Anal Cancer Risk In Women (NCT02873741) | Emory University | 2016-07-01 |
| 3BNC117 and 10-1074 in HIV-infected Individuals (NCT02825797) | Rockefeller University | 2016-06-01 |
| Tesamorelin Effects on Liver Fat and Histology in HIV (NCT02196831) | Massachusetts General Hospital | 2015-07-01 |
| CPAP Improving Mortality for Pneumonia in African Children Trial (NCT02484183) | Johns Hopkins University | 2015-06-23 |
| Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021) (NCT02403674) | Merck Sharp & Dohme LLC | 2015-06-05 |
| Regular HIV Testing Among At-Risk Latino Men (NCT02454725) | Medical College of Wisconsin | 2015-06-01 |
| A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients (NCT02388594) | University of Pennsylvania | 2015-04-01 |
| Pericardial Fat and Inflammation in HIV Patients and Controls (NCT02399384) | University of Cincinnati | 2015-01-14 |
| Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis (NCT02165202) | PATH | 2014-10-01 |
| The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients (NCT02234492) | Ottawa Heart Institute Research Corporation | 2014-09-01 |
| Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART (NCT02225665) | Sangamo Therapeutics | 2014-08-01 |
| Enhanced HIV Prevention in Couples: Feasibility Study #3 (NCT02027519) | Columbia University | 2013-12-01 |
| Assessment of Group Peer Support to Children With HIV in Vietnam (NCT02035969) | Karolinska Institutet | 2013-12-01 |
| Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults (NCT02474901) | University of Colorado, Denver | 2013-07-01 |
| Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents (NCT01849393) | St. Jude Children's Research Hospital | 2013-06-01 |
| Enhanced Prevention in Couples: Feasibility Study #2 (NCT02027441) | Columbia University | 2012-09-01 |
| Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults (NCT01685372) | University of Colorado, Denver | 2012-09-01 |
| Multi-level Determinants of Starting ART Late: Aim 3 (NCT01997359) | Columbia University | 2012-06-01 |
| Compassionate Use of Ibalizumab for the Treatment of HIV Infection (NCT02028819) | University of Colorado, Denver | 2012-01-01 |
| An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART (NCT01541085) | Janssen-Cilag S.p.A. | 2011-12-01 |
| Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r) (NCT01516970) | Janssen-Cilag G.m.b.H | 2011-11-25 |
| Multi-level Determinants of Starting ART Late: Aim 2 (NCT01997346) | Columbia University | 2011-11-01 |
| A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac) (NCT01449006) | Bruce Brew | 2011-10-01 |
| A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV (NCT01448486) | St Vincent's Hospital, Sydney | 2011-10-01 |
| An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients (NCT01615601) | Janssen Inc. | 2011-10-01 |
| Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men (NCT02572401) | University of Pennsylvania | 2011-10-01 |
| Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women (NCT01385241) | Duke University | 2011-07-01 |
| Enhanced HIV Prevention in Couples: Feasibility Study #1 (NCT02027714) | Columbia University | 2011-04-01 |
| The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System (NCT01206933) | George Washington University | 2010-07-01 |
| Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL) (NCT01875952) | Instituto Nacional de Salud Publica, Mexico | 2010-05-01 |
| A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients (NCT01199939) | Tibotec, Inc | 2010-05-01 |
| A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body (NCT01045317) | Pfizer | 2010-01-01 |
| Impact of Nutrition Intervention on HIV/AIDS Infected Patients (NCT01171495) | Caribbean Health Research Council | 2008-04-01 |
| Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission (NCT01053741) | Johns Hopkins University | 2008-03-01 |
| Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure (NCT01433601) | Karolinska Institutet | 2007-08-01 |
| ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens (NCT00335322) | Kirby Institute | 2007-02-01 |
| SPL7013 Gel - Male Tolerance Study (NCT00370357) | Starpharma Pty Ltd | 2006-08-01 |
| A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV) (NCT03407105) | Bristol-Myers Squibb | 2003-04-21 |
| A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India (NCT00992654) | ViiV Healthcare | |